Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
How would you manage an early stage HPV mediated pure adenocarcinoma of the tonsil with a large but resectable primary and multiple ipsilateral nodes without clear ECE on imaging?
Answer from: Radiation Oncologist at Academic Institution
TORS, neck dissection, and postop RT.
Sign In
or
Register
to read more
21196
Related Questions
What is the preferred neoadjuvant/adjuvant chemotherapy regimen for HPV-associated nasopharyngeal cancer?
How are you integrating the findings from KEYNOTE-689 into daily practice?
What is the role of adjuvant RT for metastatic RCC to the thyroid resected with high-risk features?
For unresectable-appearing BRAF V600E papillary thyroid cancer involving the trachea and carotid artery, is neoadjuvant targeted therapy a viable path to surgery, or is definitive radiation the better option?
How would you approach a patient with a carotid body tumor and metastasis to the cervical lymph node?
For a patient with a salivary gland tumor with evidence of local recurrence would you recommend 6 weekly fractions if giving RT alone?
How would you manage the side effects/toxicities (e.g., pain, swelling, erythema) of adjuvant EBRT to the ear for cutaneous SCC?
What dose and treatment area of radiation should be given when p16+/HPV ISH negative SCC is found in the scar of a level V lymph node excisional biopsy with all other workup negative?
Would you recommend adjuvant radiation for a patient with head/neck merkel cell carcinoma following a pathologic complete response to neoadjuvant immunotherapy?
Is there a scenario in which you would consider observation for T4a SCC involving the mandible?